Ali, Muhammad
Rigopoulos, Angelos G.
Ali, Khaldoun
Ikonomidis, Ignatios
Makavos, George
Matiakis, Marios
Melnyk, Hannes
Abate, Elena
Mammadov, Mammad
Prüser, Jan Lukas
de Vecchis, Renato
Wohlgemuth, Walter
Manginas, Athanassios
Bigalke, Boris
Mavrogeni, Sophie
Sedding, Daniel
Noutsias, Michel http://orcid.org/0000-0002-9066-5262
Article History
First Online: 1 August 2019
Compliance with ethical standards
:
: MN has received grants from the Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich Transregio 19 “Inflammatory Cardiomyopathy” (SFB TR19) (TP B2) and the University Hospital Giessen and Marburg Foundation Grant “T cell functionality” (UKGM 10/2009). MN is the local p.i. of the InterTAK Registry (until 2017: University Hospital Jena; since 2017: University Hospital Halle). MN has been a consultant to the IKDT (Institute for Cardiac Diagnosis and Therapy GmbH, Berlin) 2004–2008 and has received honoraria for presentations and/or participated in advisory boards from Abbot, Abiomed, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Fresenius, Miltenyi Biotec, Novartis, Pfizer, and Zoll. AR and MA have received honoraria for presentations from AstraZeneca. All the other authors declare that they have no conflict of interest.